Losanorm 25 Tablet contains Losartan 25 mg, an angiotensin II receptor antagonist primarily indicated for the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Losartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Losanorm 25 is also utilized in patients with diabetic nephropathy to slow the progression of kidney damage by reducing proteinuria and preserving renal function. The tablet is administered orally, with dosage tailored according to the patient’s clinical condition and response to therapy. Common adverse effects may include dizziness, headache, fatigue, and upper respiratory tract infections, though it is generally well tolerated. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated during pregnancy due to potential fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during treatment. Losanorm 25 Tablet offers an effective therapeutic option for blood pressure control and renal protection, contributing to improved cardiovascular and renal outcomes in hypertensive and at-risk patient populations.